Chad vs Papua New Guinea: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Chad
49.0%
in 2025
Papua New Guinea
44.0%
in 2025
Chad rank
156th
Papua New Guinea rank
159th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Chad
- Papua New Guinea
How they compare
Chad currently reports 49.0% against 44.0% in Papua New Guinea, a difference of 5.0%.
That makes Chad's figure about 1.1 times Papua New Guinea's.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Papua New Guinea ahead.
Chad ranks 156th and Papua New Guinea ranks 159th of 194 countries.
Papua New Guinea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 14.6% | 14.6% | Papua New Guinea |
| 2020s | 8.2% | 37.8% | 29.7% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Chad or Papua New Guinea?
- Chad, at 49.0% against 44.0% in Papua New Guinea as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Chad and Papua New Guinea?
- 5.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Papua New Guinea?
- 18 years are reported by both, from 2008 to 2025.
- How do Chad and Papua New Guinea rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Chad ranks 156th and Papua New Guinea ranks 159th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.